Understanding glycan-sensitive vs glycan-agnostic PD-1 antibodies using 3decision 2.0
In this use case, we have compared the different binding modes of PD-1 and its therapeutic antibodies to understanding its glycosylation landscape critical for guiding the development of next-generation immunotherapeutics.
Discover the key findings from three pivotal 2024 papers and how the 3decision 2.0 new feature can be used to visualize and explore these findings.
What's new in 3decision® 2021.1?
The updated 3decision® version has some important new features for cross-team collaboration and structure-based drug design project management. A lot of improvements are made on the structure visualization UI as well.
3decision 2018.3
-
Added structure collections: Enabling superposition of unrelated structures
-
New on-boarding tutorials
-
Created structure relation
-
Added GPCR annotations
-
Added visualization of ligand contacts
-
Search for in-house compounds
-
Added detailed crystallographic information
-
Enabled post-filtering of search results
-
New RESTful endpoint for data download and structure registration